Phase
Condition
Parkinson's Disease
Dyskinesias
Treatment
Interviews and Surveys
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Objective 1 (chart review):
Chinese or Vietnamese ethnicity
Age: 18 years of age or older
Diagnosed or presented for PD care at the Tufts Medical Center (TMC) MovementDisorders Clinic (MDC) from January 1, 2010 to December 31, 2019.
- Objective 2 (qualitative study):
Asian American person diagnosed with PD:
Diagnosed with PD
Chinese or Vietnamese ethnicity
Age: 18 years of age or older
Able to participate in an interview by phone or on Zoom
Able to provide informed consent
Primary caregivers of Asian American PD patients recruited into the study:
Age: 18 years of age or older
First-degree family member or spouse
Self-identified as a primary caregiver of an Asian American person with PD
Able to participate in an interview by phone or on Zoom
Able to provide informed consent
Clinicians:
Any clinician (e.g. primary care provider, neurologist, resident, nurse,nurse practitioner, etc) that takes care of PD patients.
Age: 18 years of age or older
Key advocates in the Asian American community working specifically with theAsian elderly population.
Employee or volunteer for a community-based organization working with theAsian elderly population (e.g. Greater Boston Chinese Golden Age Center,South Cove Manor, and Midtown Home Health Services) or other organizationsworking with PD patients and the elderly (e.g. Massachusetts Council onAging and the Massachusetts Chapter of the American Parkinson's DiseaseAssociation)
Age: 18 years of age or older
Able to participate in a focus group discussion on Zoom Objective 3 (surveys of care partners of Asian American individuals withPD):
Chinese or Vietnamese ethnicity
Primary care partner of a family member with Parkinson's Disease
Age: 18 years of age or older
Care partner or family member with Parkinson's Disease must be of Asian descent
Exclusion
Exclusion Criteria:
Objective 1:
- Patients diagnosed with juvenile-onset Parkinson's Disease
Objective 2:
PD patients only:
Patients with juvenile-onset Parkinson's Disease
Patients diagnosed with dementia
Patients on medication for cognitive impairment, e.g., anti-psychotics, donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne)
No exclusion criteria for other stakeholder groups (caregivers, clinical providers, key community advocates).
Objective 3:
- Patients with juvenile-onset Parkinson's Disease
Study Design
Connect with a study center
Tufts University School of Medicine
Boston, Massachusetts 02111
United StatesActive - Recruiting
Tufts University School of Medicine
Scituate, Massachusetts 02066
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.